BONEX — BoneSupport Holding AB Share Price
0.000.00%
Last trade - 00:00- SEK20.70bn
- SEK20.44bn
- SEK898.73m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 67.92 | ||
| PEG Ratio (f) | 1.53 | ||
| EPS Growth (f) | 79.78% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 27.94 | ||
| Price to Tang. Book | 28.5 | ||
| Price to Free Cashflow | 227.99 | ||
| Price to Sales | 20.74 | ||
| EV to EBITDA | 117.48 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 21.88% | ||
| Return on Equity | 18.6% | ||
| Operating Margin | 16.39% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | 180.86 | 212.88 | 328.82 | 591.08 | 898.73 | 1,279.75 | 1,743.08 | 42.04% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | -46.24 | +78.43 | +81.27 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Bonesupport Holding AB is a Sweden-based orthobiologics company. It develops and commercialize injectable bioceramic bone graft substitutes which remodel to host bone and have the capability to elute drugs directly into the bone void. The marketed synthetic bone graft substitutes are CERAMENT BVF, CERAMENT G and CERAMENT V, which are based on the CERAMENT technology platform. The products are commercially available in Europe and the United States, as well as in India, Malaysia, Oman and Singapore. The products are developed to treat patients with fractures and bone voids caused by trauma and related surgery, as well as caused by infection or diseases, such as chronic osteomyelitis, revision arthroplasty and infected diabetic foot.
Directors
- Lennart Johansson CHM (66)
- Emil Billback CEO (49)
- Hakan Johansson CFO (56)
- Fergus MacLeod EVP (51)
- Michael Roth EVP (58)
- Annelie Vikner EVP (48)
- Michael Diefenbeck EVP (45)
- Kristina Ingvar EVP (49)
- Johan Olsson EVP (54)
- Helena Brandt DHR (54)
- Bjorn Odlander DRC (63)
- Hakan Bjorklund IND (65)
- Tone Kvale IND (51)
- Lars Lidgren IND (77)
- Last Annual
- December 31st, 2024
- Last Interim
- March 31st, 2025
- Incorporated
- March 15th, 2010
- Public Since
- June 21st, 2017
- No. of Employees
- 140
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- OMX Nordic Exchange Stockholm
- Shares in Issue
- 66,764,350
- Address
- Scheelevagen 19, LUND, 223 70
- Web
- https://www.bonesupport.com
- Phone
- +46 462865370
- Contact
- Hakan Johansson
- Auditors
- Ernst & Young AB
Upcoming Events for BONEX
Bonesupport Holding AB Annual Shareholders Meeting
Q2 2025 Bonesupport Holding AB Earnings Release
Q3 2025 Bonesupport Holding AB Earnings Release
Similar to BONEX
Biogaia AB
OMX Nordic Exchange Stockholm
Camurus AB
OMX Nordic Exchange Stockholm
Cinclus Pharma Holding publ AB
OMX Nordic Exchange Stockholm
Corline Biomedical AB
OMX Nordic Exchange Stockholm
Dicot Pharma AB
OMX Nordic Exchange Stockholm
FAQ
What is the BoneSupport Holding AB share price?
As of Today at 19:40 UTC, shares in BoneSupport Holding AB are trading at SEK310.00. This share price information is delayed by 15 minutes.
How has the BoneSupport Holding AB share price performed this year?
Shares in BoneSupport Holding AB last closed at SEK310.00 and the price had moved by +35.25% over the past 365 days. In terms of relative price strength the BoneSupport Holding AB share price has outperformed the FTSE Global All Cap Index by +27.22% over the past year.
What are the analyst and broker recommendations for BoneSupport Holding AB?
The overall consensus recommendation for BoneSupport Holding AB is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the BoneSupport Holding AB dividend yield?
BoneSupport Holding AB does not currently pay a dividend.
Does BoneSupport Holding AB pay a dividend?
BoneSupport Holding AB does not currently pay a dividend.
When does BoneSupport Holding AB next pay dividends?
BoneSupport Holding AB does not currently pay a dividend.
How do I buy BoneSupport Holding AB shares?
To buy shares in BoneSupport Holding AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of BoneSupport Holding AB?
As of the previous close price of SEK310.00, shares in BoneSupport Holding AB had a market capitalisation of SEK20.70bn.
Where are BoneSupport Holding AB shares listed?
Here are the trading details for BoneSupport Holding AB:
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: BONEX
What kind of share is BoneSupport Holding AB?
Based on an overall assessment of its quality, value and momentum BoneSupport Holding AB is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a BoneSupport Holding AB share price forecast for 2025?
The analyst consensus target price for shares in BoneSupport Holding AB is SEK433.50. That is 39.84% above the last closing price of SEK310.00.
Analysts covering BoneSupport Holding AB currently have a consensus Earnings Per Share (EPS) forecast of SEK3.58 for the next financial year.
Find out moreWhat is the trend in the BoneSupport Holding AB share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like BoneSupport Holding AB. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -12.64%.
As of the last closing price of SEK310.00, shares in BoneSupport Holding AB were trading -5.87% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the BoneSupport Holding AB PE Ratio?
The BoneSupport Holding AB PE ratio based on its reported earnings over the past 12 months is 67.92. The shares last closed at SEK310.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of BoneSupport Holding AB?
BoneSupport Holding AB's management team is headed by:
- Lennart Johansson - CHM
- Emil Billback - CEO
- Hakan Johansson - CFO
- Fergus MacLeod - EVP
- Michael Roth - EVP
- Annelie Vikner - EVP
- Michael Diefenbeck - EVP
- Kristina Ingvar - EVP
- Johan Olsson - EVP
- Helena Brandt - DHR
- Bjorn Odlander - DRC
- Hakan Bjorklund - IND
- Tone Kvale - IND
- Lars Lidgren - IND